LARIMAR THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 93587000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2020-01-01 – 2020-12-31
Statuscurrent
EntityLARIMAR THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-21-011003 · Open the official SEC filing →
Retrieved: 2026-08-19T13:12:16.797926+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001374690/cashflow-financing/2020-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ee319a83-4a35-49f2-bbfe-bc2b7f43401d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies